SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-20-003203
Filing Date
2020-09-21
Accepted
2020-09-21 08:03:21
Documents
3
Period of Report
2020-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cns_8k.htm 8-K 33582
2 PURCHASE AGREEMENT cns_ex1001.htm EX-10.1 243621
3 REGISTRATION RIGHTS AGREEMENT cns_ex1002.htm EX-10.2 84802
  Complete submission text file 0001683168-20-003203.txt   363205
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 201185220
SIC: 2834 Pharmaceutical Preparations